VPIM
BEAM icon

Vanguard Personalized Indexing Management’s Beam Therapeutics BEAM Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$236K Buy
+9,910
New +$275K ﹤0.01% 1738
2025
Q1 		– Sell
-8,155
Closed -$202K – 1853
2024
Q4 		$202K Buy
+8,155
New +$208K ﹤0.01% 1523
2024
Q2 		– Sell
-7,630
Closed -$252K – 1703
2024
Q1 		$252K Buy
+7,630
New +$238K 0.01% 1344
2023
Q4 		– Sell
-8,993
Closed -$216K – 1570
2023
Q3 		$216K Buy
+8,993
New +$241K 0.01% 1272

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Vanguard Personalized Indexing Management's BEAM Position: Q1 2026 in Review

Vanguard Personalized Indexing Management opened a new position in Beam Therapeutics (BEAM) in Q1 2026: 9,910 shares worth $236K. The stake represents ﹤0.01% of the portfolio and ranks #1738 among its holdings. This is a return to the name: Vanguard Personalized Indexing Management previously reported a position in BEAM as recently as Q4 2024.

Vanguard Personalized Indexing Management first reported a position in BEAM in Q3 2023 and has held it in 4 quarters since. The position peaked at $252K in Q1 2024. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • Vanguard Personalized Indexing Management held 9,910 shares of Beam Therapeutics worth $236K as of Q1 2026.
  • Beam Therapeutics was a new Vanguard Personalized Indexing Management position in Q1 2026.
  • Beam Therapeutics made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q1 2026, its #1738 holding.
  • Vanguard Personalized Indexing Management first reported a position in Beam Therapeutics in Q3 2023 and has held it in 4 quarters since.
  • Vanguard Personalized Indexing Management's Beam Therapeutics position peaked at $252K in Q1 2024.
  • 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q1 2026, filed 14 May 2026.